Cite
HARVARD Citation
Grande, E. et al. (n.d.). 2540 Experience with radium-223 as a systemic treatment for patients (pts) with castration-resistant prostate cancer (CRPC) out of a clinical trial in Spain. European journal of cancer. pp. S488-S489. [Online].